Anticholinergic Cognitive Burden Scale: Caution with Cognitively Impaired Clients

Friday, October 31, 2014 4:02 PM | Anonymous

I'm so glad to have found this information. This list eases my burden of researching all my patients drugs for hidden implications that there may be anticholinergic effects, confounding my effectiveness with cognitively impaired clients.

Follow the links below to see a couple of versions of this list of medications. The Anticholinergic Cognitive Burden Scale (ACB scale) was developed by Dr. Boustani of the Regenstrief Institute and the Indiana University Center for Aging Research.

The scale scores medications between 1 - 3, with a score of 1 given to medications which has plausible but unproven anticholinergic effects. A score of 2-3 has established and clinically relevant anticholinergic effects.

Harvard Health Publications Link HERE

Prescriber's LETTER

© 2006-2020 Southeastern Biofeedback and Clinical Neuroscience Association (SBCNA). Disclaimer | Contact Us  
Powered by Wild Apricot Membership Software